AMPLIFY THERAPEUTICS
Amplify Therapeutics is dedicated to the development of transformative, disease-modifying therapies for Gaucher disease and genetic subgroups of Parkinson's disease.
AMPLIFY THERAPEUTICS
Industry:
Biopharma Biotechnology
Founded:
2023-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Status:
Active
Total Funding:
500 K EUR
Similar Organizations
4D Molecular Therapeutics
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
CRISPR Therapeutics
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Tridiuum
Tridiuum is a digital health company that is advancing the treatment of behavioral health conditions.
Investors List
BioInnovation Institute Venture Lab
BioInnovation Institute Venture Lab investment in Pre Seed Round - Amplify Therapeutics
More informations about "Amplify Therapeutics"
HOME - Amplify Therapeutics Inc.
It’s puzzling to me that I didn’t find myself in the aesthetics industry sooner. Enter AMPLIFY THERAPEUTICS INC. In 2020, I completed a course in neuromodulator injections that helps …See details»
Amplify Therapeutics - Crunchbase Company Profile & Funding
Organization. Amplify Therapeutics . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. ... Amplify Therapeutics is dedicated to the development …See details»
Amplify Therapeutics 2025 Company Profile: Valuation, Funding ...
When was Amplify Therapeutics founded? Amplify Therapeutics was founded in 2023. Where is Amplify Therapeutics headquartered? Amplify Therapeutics is headquartered in Copenhagen, …See details»
Amplify Therapeutics - Funding, Financials, Valuation & Investors
Amplify Therapeutics is dedicated to the development of transformative, disease-modifying therapies for Gaucher disease. New. Resources. Advanced Search. ... How much funding has …See details»
Home - Amplify Therapeutics Inc.
Create Winning Experiences Design captivating events to elevate your brand Area of Practice 01 Portfolio Management We will work with you to create a personalised plan to help you achieve your financial goals. 02 Performance Reviews We will work with you to create a personalised plan to help you achieve your financial goals. 03 Financial […]See details»
Amplify Therapeutics - Products, Competitors, Financials, …
Amplify Therapeutics develops transformative and disease-modifying therapies intended to offer quality treatments for Parkinson's disease. The company provides therapies for Gaucher …See details»
Amplify Therapeutics ApS - Drug pipelines, Patents, Clinical trials ...
Jan 23, 2025 Amplify Therapeutics: Transformative, disease-modifying therapies for Gaucher disease and genetic subgroups of Parkinson's disease. Since its inception in 2018, BII has …See details»
Ten new companies enter BioInnovation Institute’s …
Mar 1, 2023 Amplify Therapeutics develops transformative, disease-modifying therapies for Gaucher disease and genetic subgroups of Parkinson’s disease. Since its inception in 2018, BII has supported 80 start-ups and projects with …See details»
Amplify Therapeutics ApS | DANISH BIO – DANSK BIOTEK
Amplify Therapeutics is developing a pipeline of First-in-class, disease-modifying therapeutics for genetically defined neurodegenerative diseases. Contact name: Thomas Kirkegaard Jensen …See details»
Amplify Therapeutics Inc. - Calgary | Alberta Corporations
Amplify Therapeutics Inc. - Incorporated in Alberta, Canada on Jun 2, 2022 at 900-332 6TH AVE SW, CALGARY ALBERTA, T2P0B2See details»
Ten new companies enter BioInnovation Institute's Venture Lab …
Mar 1, 2023 Amplify Therapeutics: Transformative, disease-modifying therapies for Gaucher disease and genetic subgroups of Parkinson's disease. Since its inception in 2018, ...See details»
CDMO AmplifyBio closes doors amid tough market for early-stage …
Apr 7, 2025 Back in December, Amplify confirmed plans to cut costs and shutter the R&D and characterization services site in South San Francisco that it had acquired from PACT in 2022. …See details»
Amplify Therapeutics Stock Price, Funding, Valuation, Revenue ...
Mar 7, 2024 Amplify Therapeutics has raised $1.42M over 1 rounds. Amplify Therapeutics's latest funding round was a Convertible Note for $1.42M on March 7, 2024. Date. Round. …See details»
Amplify Therapeutics - Crunchbase
Amplify Therapeutics is dedicated to the development of transformative, disease-modifying therapies for Gaucher disease. New. Resources. Advanced Search. ... Experience the new …See details»
Amplify Therapeutics - Drug Discovery World (DDW)
Mar 12, 2024 BioInnovation Institute (BII), life science incubator, has announced the addition of six companies who will receive additional financial support through its Venture House …See details»
Global start-ups: where is the innovation?
Apr 25, 2023 Amplify Therapeutics boasts disease-modifying therapies for Gaucher disease and genetic subgroups of Parkinson’s disease. Supporting innovative science ... the anti-ageing therapeutics market is expected to reach $2.01 billion by 2030. Dr Janette Thomas, CEO of Five Alarm Bio, said: “Whilst life expectancy has increased over recent years ...See details»
Amplify Therapeutics - Updates, News, Events, Signals & Triggers
Amplify Therapeutics is dedicated to the development of transformative, disease-modifying therapies for Gaucher disease.See details»
Amplify - 2025 Funding Rounds & List of Investors - Tracxn
5 days ago Amplify has raised a total of $215M over 2 funding rounds. One was Series C round of Undisclosed from Investors like Cox Enterprises and Emerson Collective and the other was Series C round of $215M from Investors like Learn Capital and A-Street Ventures. Here is the list of all funding rounds of . Amplify:See details»
Final decision is close: Will former Orphazyme crown jewel come …
Sep 20, 2024 Thomas Kirkegaard Jensen worked for over 11 years as director of science at Orphazyme. Today, he is affiliated with a new biotech company in the form of Amplify …See details»
AmplifyBio - APT Oncology
AmplifyBio AmplifyBio will advance the quality of human health and save lives by creating next generation platforms, tools, and services to amplify and accelerate the development of …See details»